Delivery Order SPE2DB25D3108-SPE2DB26FPBMA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Estradiol 0.06% 1.25G Gel Pump in 37.5GM units, with a ceiling value of $1,618.33. This competitively awarded, non-set-aside delivery order is scheduled for ultimate completion on November 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Estradiol 0.06% gel in 1.25-gram pump format (37.5-gram total) with a ceiling value of $1,452.40. This non-set-aside contract utilizes firm fixed price terms with an ultimate completion date of August 28, 2025, and is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on September 19, 2025, with a ceiling value of $1,114.92 and an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,315.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram units. This non-set-aside contract represents a single delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The point of performance is located at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Estradiol 0.01% Cream in 42.5-gram units. This is a firm fixed-price delivery order with a ceiling value of $1,563.30, with an ultimate completion date of September 17, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order,...
- The Defense Logistics Agency awarded a $6,211.59 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Estradiol 0.01% cream in 42.5-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,864.28 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. The award utilized no set-aside designation, indicating competitive selection among...
- The Defense Logistics Agency awarded a delivery order valued at $1,308.73 to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5gm) on October 30, 2025, with completion expected by October 31, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's broader federal contracting relationship with DLA. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.08 to AmerisourceBergen Drug Corp for the supply of Estradiol 0.01% cream in 42.5-gram quantities. This firm fixed-price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBMADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Estradiol 0.06% 1.25G gel pump in 37.5GM quantities, with a ceiling value of $1,590.50 and firm fixed pricing. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance is to be completed by October 29, 2025, with the place of performance located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, including hormone treatments such as this estradiol product, which supports endocrine and hormone replacement therapy needs within Department of Defense healthcare programs. This delivery order exemplifies the ongoing pharmaceutical procurement operations conducted through DLA's prime vendor contract vehicle to meet military medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/28/25 |